Pharmesis International Ltd (SGX:BFK) Share Price

Company Profile

Business description
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution, which refers to agency products and internally manufactured products which are marketed through the distribution arm. The company derives revenue from the sale of medicines to domestic customers in China.
Contact
5 Kallang Sector
No. 03-02
Singapore349279
SGP
T: +65 68460766
https://www.pharmesis.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees

Recommended

Shares have dropped 20% in the previous year due to concerns about tariffs.

Esther Holloway | 27 October 2025

Higher gold prices are making a difference to the bottom line but investors overly optimistic.

Jon Mills, CFA | 27 October 2025

We see faster cloud growth and improved longer-term profitability for Alphabet.

Malik Ahmed Khan, CFA | 25 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,295.80	26.20	-0.28%
CAC 40	8,226.65	12.53	-0.15%
DAX 40	24,246.72	62.06	-0.26%
Dow JONES (US)	47,544.59	337.47	0.71%
FTSE 100	9,658.86	5.04	0.05%
HKSE	26,346.14	87.56	-0.33%
NASDAQ	23,637.46	432.59	1.86%
Nikkei 225	50,219.18	293.14	-0.58%
NZX 50 Index	13,402.66	11.07	0.08%
S&P 500	6,875.16	83.47	1.23%
S&P/ASX 200	9,012.50	16.30	-0.18%
SSE Composite Index	3,988.22	8.72	-0.22%